Ceftaroline fosamil

Zinforo 600 MG Polvo Para Concentrado Para Solucion Para Perfusion

600,0 mg polvo para concentrado para solución para perfusiónSpainMarketedAuthorised 24 Oct 2012

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ceftaroline fosamil

Zinforo 600 MG Polvo Para Concentrado Para Solucion Para Perfusion

600,0 mg polvo para concentrado para solución para perfusiónSpainMarketedAuthorised 24 Oct 2012

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Zinforo®Serbia · 600mg · prašak za koncentrat za rastvor za infuziju · Pfizer SRB D.O.O.

Zinforo 600 MG I.V. VialSaudi Arabia · Acs Dobfar SPA

Zinforo Powder for Concentrate for Solution for Infusion 600mg/vialSingapore · 530 mg/vial · injection, powder, for solution · Pfizer Private Limited

Ceftarolina Fosamil QiluItaly · polvere per concentrato e soluzione per soluzione per infusione · Qilu Pharma Spain S.L.

Ceftaroline FosamilUnited States · 400MG/VIAL, 600MG/VIAL · powder · Apotex

TeflaroUnited States · 400MG/VIAL, 600MG/VIAL · powder · Abbvie

Packs

Pack	Code	Status
ZINFORO 600 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 10 viales	694011

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Ceftaroline fosamil
Strength: 600,0 mg
Dosage form: polvo para concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 24 Oct 2012
Registration: 12785001
Marketing authorisation holder: Pfizer Ireland Pharmaceuticals Unlimited Company
Procedure: EU centralised
Supply: Uso Hospitalario